hemeonclinx Medical News about mycophenolate mofetil; allogeneic hematopoietic stem cell transplantation

Click the title below to leave the MDLinx Network and go to the Journal's Website

Pharmacokinetics-based optimal dose-exploration of mycophenolate mofetil in allogeneic hematopoietic stem cell transplantation
International Journal of Hematology, 06/13/08

Email This Article

Save in My Library

Free Abstract

Okamura A et al. - These results suggest that MMF administration of every 8 h after alloSCT would be better to maintain higher MPA plasma levels than that of every 12 h even in the same daily dose. Further studies are necessary to confirm the clinical benefit of MMF to prevent graft failure, as well as severe aGVHD.

--- BMT/SCT TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email

Quality-of-Life Assessment for Routine Oncology Clinical Practice
The Journal of Supportive Oncology, 06/16/08

Allogeneic stem cell transplantation for children with acute myeloid leukemia in second complete remission
Journal of Pediatric Hematology/Oncology, 08/08/08

Multiparameter flow cytometry remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation
Blood, 08/11/08

...All of BMT/SCT

Sponsor

--- PHARMACOLOGY/THERAPY TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email

Chemotherapy in metastatic breast cancer: A summary of all randomised trials reported 2000-2007
European Journal of Cancer, 08/27/08

Statins and cancer: A systematic review and meta-analysis
European Journal of Cancer, 08/20/08

Ixabepilone: A new antimitotic for the treatment of metastatic breast cancer
Annals of Pharmacotherapy, 08/18/08

...All of Pharmacology/Therapy